DMCRX Mutual Fund

NAV$19.33

Fund Essentials - as of Dec 31, 2025

Net Assets
-
Expense Ratio
1.34%
Dividend Yield (Current)
10.24%
Holdings
131
Inception Date
Nov 18, 2013
Fund Family
Driehaus Capital Management LLC
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+19.39%
1 Year+81.62%
3 Year+31.86%
5 Year+20.37%
10 Year+34.23%

Asset Allocation

Stocks: 99.80%
Cash: 0.20%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
PRAXPraxis Precision Medicines Inc Common Stock Usd.00012.65%
CRNXCrinetics Pharmaceuticals Inc Com1.82%
REALRealreal Inc/The1.63%
PLPlanet Labs Class A1.58%
XMTRXometry, Inc. (Class A)1.46%
Top 10 Concentration: 15.97%Report Date: Dec 31, 2025
Download all 131 holdings for DMCRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
10.24%
Frequency
Annually
Latest Distribution
$7.88
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

DMCRX Mutual Fund Overview

DMCRX Mutual Fund (Driehaus Micro Cap Growth Fund) is managed by Driehaus Capital Management LLC. DMCRX expense ratio is 1.34%, holding 131 positions across sectors including Health Care, Information Technology, Unknown. Inception date: 2013-11-18.

DMCRX performance shows a YTD return of 19.39%. The 1-year return is 81.62% and the 5-year return is 20.37%. DMCRX dividend yield stands at 10.24%, paid annually.

DMCRX top holdings include Praxis Precision Medicines Inc Common Stock Usd.0001 (2.6%), Crinetics Pharmaceuticals Inc Com (1.8%), Realreal Inc/The (1.6%), Planet Labs Class A (1.6%), Xometry, Inc. (Class A) (1.5%). View all DMCRX holdings, sector breakdown, or dividend history.

DMCRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. DMCRX alternatives are available via the screener, along with tax-loss harvesting opportunities.